Health care stocks advanced Friday afternoon with the NYSE Health Care Index rising 1.6% and the Health Care Select Sector SPDR Fund (XLV) adding 1.3%.
The iShares Biotechnology ETF (IBB) climbed 1.3%.
In corporate news, Novo Nordisk (NVO) shares jumped 5.4% after Health Canada accepted for review a supplemental new drug submission for semaglutide 2.4 mg as a once weekly treatment for people with metabolic dysfunction-associated steatohepatitis.
The US Department of Justice filed a complaint in federal court alleging that three of the country's largest health insurance companies offering Medicare Advantage plans paid "hundreds of millions of dollars in kickbacks" to insurance brokers from 2016 through at least 2021 to steer beneficiaries toward their plans. The DOJ named CVS Health's (CVS) Aetna, Elevance Health (ELV) and Humana (HUM) in the case, as well as brokers eHealth (EHTH), GoHealth (GOCO) and SelectQuote. CVS shares fell 3.3%, Elevance added 0.3%, Humana rose 0.7%, eHealth fell 3.1% and GoHealth dropped 4.8%.
Adaptive Biotechnologies (ADPT) shares jumped 35%, a day after the company reported a narrower loss and higher revenue in Q1.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。